학술논문
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283
Document Type
Article
Author
Source
In Gynecologic Oncology September 2023 176:16-24
Subject
Language
ISSN
0090-8258